CN117530916A - External liquid medicine for treating eczema and preparation method thereof - Google Patents
External liquid medicine for treating eczema and preparation method thereof Download PDFInfo
- Publication number
- CN117530916A CN117530916A CN202311824140.6A CN202311824140A CN117530916A CN 117530916 A CN117530916 A CN 117530916A CN 202311824140 A CN202311824140 A CN 202311824140A CN 117530916 A CN117530916 A CN 117530916A
- Authority
- CN
- China
- Prior art keywords
- liquid medicine
- treating eczema
- external liquid
- medicine
- eczema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 83
- 239000003814 drug Substances 0.000 title claims abstract description 81
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 76
- 239000007788 liquid Substances 0.000 title claims abstract description 66
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 20
- 229940037003 alum Drugs 0.000 claims abstract description 16
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000206469 Pulsatilla Species 0.000 claims abstract description 15
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229940116229 borneol Drugs 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 14
- 241001106477 Paeoniaceae Species 0.000 claims abstract description 14
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 14
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 14
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 240000000774 Cunila origanoides Species 0.000 claims description 10
- 235000018274 Cunila origanoides Nutrition 0.000 claims description 10
- 235000014866 Dictamnus albus Nutrition 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000003113 dilution method Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000009806 pulsatillae Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims 4
- 230000000699 topical effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 208000003251 Pruritus Diseases 0.000 abstract description 25
- 230000007803 itching Effects 0.000 abstract description 22
- 230000008591 skin barrier function Effects 0.000 abstract description 7
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 6
- 238000003745 diagnosis Methods 0.000 description 11
- 208000010201 Exanthema Diseases 0.000 description 10
- 201000005884 exanthem Diseases 0.000 description 10
- 206010037844 rash Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 235000019658 bitter taste Nutrition 0.000 description 9
- 238000004321 preservation Methods 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 description 3
- 241000123887 Pulsatilla chinensis Species 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000223238 Trichophyton Species 0.000 description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 229960001508 levocetirizine Drugs 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 2
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 244000236658 Paeonia lactiflora Species 0.000 description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- ACVGWSKVRYFWRP-UHFFFAOYSA-N Rutecarpine Chemical compound C1=CC=C2C(=O)N(CCC=3C4=CC=CC=C4NC=33)C3=NC2=C1 ACVGWSKVRYFWRP-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 241000212749 Zesius chrysomallus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 229940065181 bacillus anthracis Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229930014456 matrine Natural products 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 231100000046 skin rash Toxicity 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BBTIMXAYZRWPNG-UHFFFAOYSA-N 3beta,Delta4-stigmasten-3-ol Natural products C1CC2=CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BBTIMXAYZRWPNG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000219317 Amaranthaceae Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- ZROGCCBNZBKLEL-FHXNIQKESA-N Astilbin Natural products O([C@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 ZROGCCBNZBKLEL-FHXNIQKESA-N 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- BCPAKGGXGLGKIO-UHFFFAOYSA-N Pseudorutaecarpin Natural products C1=CC=C2C(=O)N(CCC3=C4C5=CC=CC=C5N3)C4=NC2=C1 BCPAKGGXGLGKIO-UHFFFAOYSA-N 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241000362909 Smilax <beetle> Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003616 anti-epidemic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- ZROGCCBNZBKLEL-MPRHSVQHSA-N astilbin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1C(=O)C2=C(O)C=C(O)C=C2O[C@@H]1C1=CC=C(O)C(O)=C1 ZROGCCBNZBKLEL-MPRHSVQHSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- QADVIPISOOQJMJ-WLKYTNTRSA-N beta-stigmasterol Natural products CCC(CC)C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@H]1CC[C@H]3[C@H]2CC=C4C[C@@H](O)CC[C@]34C QADVIPISOOQJMJ-WLKYTNTRSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 230000002905 effect on arthritis Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000005977 kidney dysfunction Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- HCXVJBMSMIARIN-UHFFFAOYSA-N stigmasterol Chemical compound C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 HCXVJBMSMIARIN-UHFFFAOYSA-N 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an external liquid medicine for treating eczema and a preparation method thereof, wherein the external liquid medicine comprises the following components in parts by weight: 20-30g of kuh-seng, 6-12g of amur corktree bark, 6-12g of red paeony root, 20-30g of glabrous greenbrier rhizome, 20-30g of Chinese pulsatilla root, 0.5-0.7g of borneol, 10-15g of belvedere fruit, 10-15g of cortex dictamni and 10-15g of dried alum. The external liquid medicine for treating eczema, the preparation method and the application thereof expand the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect is enhanced, the effects of clearing heat, removing dampness, dispelling wind and relieving itching of kuh-seng, cortex phellodendri, radix paeoniae rubra, glabrous greenbrier rhizome, pulsatilla root, borneol, fructus kochiae, cortex dictamni and dried alum are utilized, the effects of clearing damp and removing heat, detoxicating and resolving dampness, dispelling wind and relieving itching can be realized, the eczema can be effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat and moisture are preserved, the medicine is suitable for popularization and application, the skin is kept moist, the skin barrier is repaired, and the skin inflammation is resolved.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an external liquid medicine for treating eczema, a preparation method and application thereof.
Background
Eczema is a skin inflammatory reaction with severe itching caused by various internal and external factors. The three phases of acute, subacute and chronic are divided. Acute exudation tends, while chronic exudation tends to wet and thicken. Some patients directly manifest as chronic eczema. Skin injury has the characteristics of polymorphism, symmetry, itching, easy repeated attack and the like. Eczema is statistically up to 30% in children and about 10% in adults in developed countries; and researches show that the prevalence rate of eczema in developing countries tends to increase due to rapid environmental changes of rapid economic growth. Eczema usually starts in childhood, affects about 30% of children, may aggravate in adolescents and adults, causes symptoms such as refractory itching, pain and infection, and has an incidence rate of more than 10%, and is in an ascending trend.
Clinically, lifestyle and drugs are changed to treat eczema, and the drugs are classified into antihistamines and biological agents, and clinical first-line treatment drugs have general curative effects and certain adverse reactions, for example, levocetirizine may have symptoms such as renal dysfunction and headache, and the like, and the dulcitol Li Youshan is resistant to conjunctivitis and systemic hypersensitivity.
The traditional Chinese medicine has thousands of years history, eczema belongs to the category of damp sore, exogenous evil invasion, weakness of spleen and stomach, improper diet can cause the occurrence of the damp sore, improper diet is the most common cause of modern society, and the spleen and stomach transport and transformation function is weakened, spleen deficiency and damp stagnation are caused, heat is transformed for a long time, evil of damp heat blocks meridians, the traditional Chinese medicine treatment generally takes clearing heat and promoting diuresis, dispelling wind and relieving itching as the main part, and in view of the above, the development of an external medicine liquid for treating eczema, a preparation method and application thereof are necessary to overcome the defects of the prior art.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides an external liquid medicine for treating eczema, a preparation method and application thereof, which have the advantages of keeping skin moist, repairing skin barrier, eliminating skin inflammation and obvious curative effect, and solve the problems that the medicines are clinically used for treating eczema by changing life style and are divided into antihistamine medicines and biological preparation medicines, the curative effect of the first-line clinical treatment medicines is general and has certain adverse reaction, for example, symptoms such as kidney dysfunction, headache and the like can occur in levocetirizine, and conjunctivitis and systemic hypersensitivity can occur in the anti-epidemic of the dutchmanspipe Li Youshan.
In order to achieve the above purpose, the present invention provides the following technical solutions: an external liquid medicine for treating eczema comprises the following components in parts by weight: 20-30g of kuh-seng, 6-12g of amur corktree bark, 6-12g of red paeony root, 20-30g of glabrous greenbrier rhizome, 20-30g of Chinese pulsatilla root, 0.5-0.7g of borneol, 10-15g of belvedere fruit, 10-15g of cortex dictamni and 10-15g of dried alum.
Further, the external liquid medicine for treating eczema also comprises the following components in parts by weight: 20g of kuh-seng, 6g of amur corktree bark, 6g of red paeony root, 20g of glabrous greenbrier rhizome, 20g of Chinese pulsatilla root, 0.5g of borneol, 10g of belvedere fruit, 10g of dittany bark and 10g of dried alum.
Further, the external liquid medicine for treating eczema also comprises the following components in parts by weight: 25g of kuh-seng, 10g of amur corktree bark, 10g of red paeony root, 25g of glabrous greenbrier rhizome, 25g of Chinese pulsatilla root, 0.6g of borneol, 12g of belvedere fruit, 12g of dittany bark and 12g of dried alum.
Further, the external liquid medicine for treating eczema also comprises the following components in parts by weight: 30g of kuh-seng, 12g of amur corktree bark, 12g of red paeony root, 30g of glabrous greenbrier rhizome, 30g of Chinese pulsatilla root, 0.7g of borneol, 15g of belvedere fruit, 15g of dittany bark and 15g of dried alum.
The application also provides a preparation method of the external liquid medicine for treating eczema, which comprises the following steps:
a. cleaning radix Sophorae Flavescentis, cortex Phellodendri, radix Paeoniae Rubra, rhizoma Smilacis Glabrae, radix Pulsatillae, kochiae fructus, and cortex Dictamni Radicis, respectively, cutting into small pieces, and soaking in water in a decoction pot;
b. decocting the soaked medicinal materials;
c. adding Borneolum Syntheticum and Alumen at a certain proportion 5 min before decocting;
d. filtering the decoction to obtain concentrated Chinese medicinal liquid;
e. adding purified water to dilute the concentrated Chinese medicinal liquid according to the disease condition to obtain the final Chinese medicinal liquid.
Further, the soaking time in the step a is 2-3 hours, and the decocting time in the step b is 2-3 hours.
Further, after the step d is finished, the decoction is filtered by using a gauze bag, wherein the mesh number of the gauze bag is 300 meshes.
Further, the dilution method in the step e is to dilute the concentrated liquid medicine with purified water according to the ratio of 1:3, 1:5 and 1:10.
The application also provides the external liquid medicine for treating eczema and the application of the preparation method of the external liquid medicine for treating eczema in treating eczema.
Compared with the prior art, the technical scheme of the application has the following beneficial effects:
the external liquid medicine for reducing and treating eczema, the preparation method and the application thereof expand the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect is enhanced, the dampness and heat are removed, the toxin is removed, the dampness is removed, the wind is dispelling and the itching is relieved, the eczema is effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat preservation and the moisture preservation are realized, the medicine is suitable for popularization and application, the skin moistening is kept, the skin barrier is repaired, the skin inflammation is resolved, and the curative effect is remarkable.
Drawings
FIG. 1 is a flow chart of the preparation method of the invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Embodiment one:
referring to fig. 1, an external liquid medicine for treating eczema in this embodiment includes the following components in parts by weight: 20g of kuh-seng, 6g of amur corktree bark, 6g of red paeony root, 20g of glabrous greenbrier rhizome, 20g of Chinese pulsatilla root, 0.5g of borneol, 10g of belvedere fruit, 10g of dittany bark and 10g of dried alum.
The application also provides a preparation method of the external liquid medicine for treating eczema, which comprises the following steps:
a. cleaning radix Sophorae Flavescentis, cortex Phellodendri, radix Paeoniae Rubra, rhizoma Smilacis Glabrae, radix Pulsatillae, kochiae fructus, and cortex Dictamni Radicis, respectively, cutting into small pieces, and soaking in water in a decoction pot;
b. decocting the soaked medicinal materials;
c. adding Borneolum Syntheticum and Alumen at a certain proportion 5 min before decocting;
d. filtering the decoction to obtain concentrated Chinese medicinal liquid;
e. adding purified water to dilute the concentrated Chinese medicinal liquid according to the disease condition to obtain the final Chinese medicinal liquid.
Further, the soaking time in the step a is 2 hours, and the decocting time in the step b is 2 hours.
Further, after the step d is finished, the decoction is filtered by using a gauze bag, wherein the mesh number of the gauze bag is 300 meshes.
Further, the dilution method in the step e is to dilute the concentrated liquid medicine with purified water according to a ratio of 1:3.
Wherein, an external liquid medicine for treating eczema and a preparation method of the external liquid medicine for treating eczema are applied to treating eczema.
The beneficial effects of the embodiment are as follows: the external liquid medicine for treating eczema expands the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect can be enhanced, the dampness and heat can be removed, the detoxication and dampness can be removed, the wind and the itching can be removed, the eczema can be effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat preservation and the moisture preservation are realized, the application is convenient, the skin moistening can be maintained, the skin barrier can be repaired, the skin inflammation can be resolved, and the curative effect is obvious.
Embodiment two:
referring to fig. 1, an external liquid medicine for treating eczema in this embodiment includes the following components in parts by weight: 25g of kuh-seng, 10g of amur corktree bark, 10g of red paeony root, 25g of glabrous greenbrier rhizome, 25g of Chinese pulsatilla root, 0.6g of borneol, 12g of belvedere fruit, 12g of dittany bark and 12g of dried alum.
The application also provides a preparation method of the external liquid medicine for treating eczema, which comprises the following steps:
a. cleaning radix Sophorae Flavescentis, cortex Phellodendri, radix Paeoniae Rubra, rhizoma Smilacis Glabrae, radix Pulsatillae, kochiae fructus, and cortex Dictamni Radicis, respectively, cutting into small pieces, and soaking in water in a decoction pot;
b. decocting the soaked medicinal materials;
c. adding Borneolum Syntheticum and Alumen at a certain proportion 5 min before decocting;
d. filtering the decoction to obtain concentrated Chinese medicinal liquid;
e. adding purified water to dilute the concentrated Chinese medicinal liquid according to the disease condition to obtain the final Chinese medicinal liquid.
Further, the soaking time in the step a is 3 hours, and the decocting time in the step b is 3 hours.
Further, after the step d is finished, the decoction is filtered by using a gauze bag, wherein the mesh number of the gauze bag is 300 meshes.
Further, the dilution method in the step e is to dilute the concentrated liquid medicine with purified water according to a ratio of 1:5.
Wherein, an external liquid medicine for treating eczema and a preparation method of the external liquid medicine for treating eczema are applied to treating eczema.
The beneficial effects of the embodiment are as follows: the external liquid medicine for treating eczema expands the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect can be enhanced, the dampness and heat can be removed, the detoxication and dampness can be removed, the wind and the itching can be removed, the eczema can be effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat preservation and the moisture preservation are realized, the application is convenient, the skin moistening can be maintained, the skin barrier can be repaired, the skin inflammation can be resolved, and the curative effect is obvious.
Embodiment III:
referring to fig. 1, an external liquid medicine for treating eczema in this embodiment includes the following components in parts by weight: 30g of kuh-seng, 12g of amur corktree bark, 12g of red paeony root, 30g of glabrous greenbrier rhizome, 30g of Chinese pulsatilla root, 0.7g of borneol, 15g of belvedere fruit, 15g of dittany bark and 15g of dried alum.
The application also provides a preparation method of the external liquid medicine for treating eczema, which comprises the following steps:
a. cleaning radix Sophorae Flavescentis, cortex Phellodendri, radix Paeoniae Rubra, rhizoma Smilacis Glabrae, radix Pulsatillae, kochiae fructus, and cortex Dictamni Radicis, respectively, cutting into small pieces, and soaking in water in a decoction pot;
b. decocting the soaked medicinal materials;
c. adding Borneolum Syntheticum and Alumen at a certain proportion 5 min before decocting;
d. filtering the decoction to obtain concentrated Chinese medicinal liquid;
e. adding purified water to dilute the concentrated Chinese medicinal liquid according to the disease condition to obtain the final Chinese medicinal liquid.
Further, the soaking time in the step a is 2.5 hours, and the decocting time in the step b is 2.5 hours.
Further, after the step d is finished, the decoction is filtered by using a gauze bag, wherein the mesh number of the gauze bag is 300 meshes.
Further, the dilution method in the step e is to dilute the concentrated liquid medicine with purified water according to a ratio of 1:10.
Wherein, an external liquid medicine for treating eczema and a preparation method of the external liquid medicine for treating eczema are applied to treating eczema.
The beneficial effects of the embodiment are as follows: the external liquid medicine for treating eczema expands the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect can be enhanced, the dampness and heat can be removed, the detoxication and dampness can be removed, the wind and the itching can be removed, the eczema can be effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat preservation and the moisture preservation are realized, the application is convenient, the skin moistening can be maintained, the skin barrier can be repaired, the skin inflammation can be resolved, and the curative effect is obvious.
Meanwhile, the kuh-seng is perennial sub-shrub of the genus Sophora of the family Leguminosae, has bitter taste, cold property, heart, liver, stomach, large intestine and bladder meridian, has the effects of clearing heat, drying dampness, killing parasites and promoting urination, is used for treating dysentery, hematochezia, jaundice, leucorrhea with reddish discharge, swelling of yin, pruritus vulvae, eczema, skin pruritus and the like, and has the pharmacological effects of matrine and oxymatrine on hepatitis B virus, hepatitis C virus, coxsackie virus and adenovirus, and has the effects of inhibiting dermatophytes such as trichophyton, epizoon rubrum and the like to different degrees; matrine and oxymatrine have antiinflammatory and antiallergic effects.
Cortex Phellodendri is dry bark of phellodendron bark of Rutaceae, has bitter taste, cold property, kidney and bladder meridian, has effects of clearing heat and drying dampness, purging pathogenic fire and removing steam, and removing toxic substance and treating sore, and can be used for treating damp-heat dysentery, jaundice and dark urine, itching and pain of lower vagina, eczema and wet sore, etc., and network pharmacological research shows that active components of cortex Phellodendri, quercetin, rutaecarpine, beta-sitosterol, stigmasterol and dehydrotanshinone IIA have high network moderate value, and can inhibit inflammation and antioxidant stress, thereby treating eczema.
The red paeony root is the dried root of the Paeonia lactiflora or Paeonia lactiflora of Ranunculaceae, has bitter taste, slightly cold nature and liver meridian, has the effects of clearing heat and cooling blood, and removing stasis and relieving pain, is used for treating heat entering nutrient blood, warming toxin and generating spots, hematemesis and epistaxis, conjunctival congestion and swelling pain, liver Yu Xie pain, amenorrhea and dysmenorrhea, abdominal pain, traumatic injury, carbuncle swelling and sore and the like, has obvious inhibition effect on arthritis induced by different adjuvants by the paeoniflorin, and can improve allergic inflammatory reaction induced by IgE complex; paeoniflorin has effects of relieving fever, relieving pain, and tranquilizing.
Rhizoma Smilacis Glabrae is tuber of Smilax genus plant of Smilaxaceae family, has sweet and light taste, has effects of removing toxic substance, removing dampness, and dredging joint, and can be used for treating limb contracture and tendons and bones pain caused by syphilis and mercuric poisoning; damp-heat stranguria with turbid urine, leukorrhagia, carbuncle, scrofula, scabies, etc.
The pulsatilla chinensis is the dry root of pulsatilla chinensis belonging to the Ranunculaceae, has bitter taste, cold property, enters stomach and large intestine channels, has the effects of clearing heat and detoxicating, cooling blood and stopping dysentery, is used for treating heat toxin bloody dysentery, pruritus vulvae leukorrhagia and the like, and has the research finding that the pulsatilla chinensis decoction has better effect of killing amoeba in a dissolved tissue. The pulsatilla root water extract has obvious inhibition effect on staphylococcus aureus, pseudomonas aeruginosa, bacillus anthracis, typhoid bacillus, streptococcus A and streptococcus B.
The fructus Kochiae is a dry mature fruit of Kochiae fructus belonging to Chenopodiaceae, has pungent and bitter taste, has effects of clearing heat and promoting diuresis, dispelling pathogenic wind and relieving itching, and can be used for treating urination pain, pruritus vulvae, leukorrhagia, rubella, eczema, skin pruritus, etc.
The cortex Dictamni is root bark of Rutaceae perennial herb, such as cortex Dictamni Radicis and herba Angustifoliae She Baixian, has bitter taste and cold nature, enters spleen, stomach and bladder channels, has effects of clearing heat and eliminating dampness, dispelling pathogenic wind and removing toxic substances, and can be used for treating damp-heat sore, yellow Shui Linli, eczema, rubella, scabies and scabies, rheumatic arthralgia, etc., and the water infusion of cortex Dictamni has various degrees of inhibiting effects on multiple pathogenic fungi such as trichophyton, trichophyton, bacillus pumilus, epidermophyton, nocardia stellate, etc., and has antiinflammatory and antipyretic effects. Pharmacological research shows that astilbin contained in the product has obvious diuretic and analgesic effects. Has inhibiting effects on Staphylococcus aureus, hemolytic streptococcus, escherichia coli, pseudomonas aeruginosa, typhoid bacillus, dysentery bacillus, diphtheria bacillus and bacillus anthracis.
The borneol is prepared by extracting and processing fresh branches and leaves of camphor of Lauraceae, has pungent and bitter taste, cool nature, returns heart, spleen and lung channels, has the effects of inducing resuscitation and refreshing mind, and clearing heat and relieving pain, is used for treating febrile diseases such as unconsciousness, convulsion, apoplexy and phlegm syncope, qi stagnation syncope, middle-malignant coma, chest stuffiness and pain, conjunctival congestion, aphtha, sore throat, ear canal purulence and the like, and has obvious antibacterial effect on staphylococcus aureus, beta hemolytic streptococcus, streptococcus grass, pneumococcus, escherichia coli and the like in a test tube, and has the effects of low-concentration bacteriostasis and high-concentration bacteriostasis.
The dried alum is calcined alum, has sour and astringent taste, is cold in nature and toxic, enters lung, spleen, stomach and large intestine channels, has the functions of astringing, drying dampness and relieving itching, and is used for treating epilepsy, sore throat, excessive guilt saliva, hepatitis, jaundice, yellow swelling, gastric ulcer, duodenal ulcer, uterine prolapse, leucorrhea, diarrhea, epistaxis, aphtha of the mouth and tongue, sore, hemorrhoids and mange, water, fire, insect injury and the like.
Typical cases
1. Case 1
Liu Mou women, 43 years old, company staff
The skin of the whole body had rash and subjective itching 3 years ago. Western medicine is applied for treating the disease (detailed in detail) with repeated attack, mild time and severe time. For nearly 2 months, the disease is repeated, the pruritus is severe, the disease is not controlled, and the diagnosis is carried out. The following symptoms are shown in the following formula: erythema, pimple, and wind mass, which are of different sizes, develop on the trunk and extremities, mostly merge into flakes with scratches, scabs, and desquamation. Bitter taste, normal urine, constipation, insomnia, red tongue with yellow and greasy coating, slippery and rapid pulse. Western diagnosis: eczema, diagnosis of traditional Chinese medicine: the liquid medicine 14 of the invention is used for treating the wet sore, 1 dose per day is used for washing the affected part, and the treatment is repeated once in the morning and at night: the patient was re-diagnosed after 14 doses again with a decrease in the itching, the rash was substantially resolved and the skin was visibly reddish-pigmented.
2. Case 2
Zhang Mou Man, 37 years old, company staff
The patient was found to develop rash on both palms with itching 1 week ago. The eczema is traced back, once in western medicine hospital treatment, the levocetirizine hydrochloride tablet is orally taken, and the externally applied budesonide ointment is relieved once daily, but the curative effect is not obvious, and the diagnosis is carried out. The following symptoms are shown in the following formula: the two upper limbs develop red spots and pimples with different sizes, the rash is light red to bright red, and the two upper limbs are partially fused into pieces with scratch and scab. Subjective itching. The patient can feel the heaviness of the body, insomnia, yellow and greasy coating and slippery pulse. Western diagnosis: eczema, diagnosis of traditional Chinese medicine: the liquid medicine 14 of the invention is used for treating the wet sore, 1 dose per day is used for washing the affected part, and the treatment is repeated once in the morning and at night: the skin rash of the patient becomes light in color, the itching feeling is relieved, and the skin rash is basically resolved after the repeated diagnosis after 7 doses.
3. Case 3
Li Mou female, 35 year old, individual
Patients have improper diet for more than 1 month due to working reasons, are addicted to sweet and thick taste, have improper drinking, and have rash and itching on the waist and less abdomen before 3 days, and the external calamine lotion has no obvious curative effect for diagnosis. The following symptoms are shown in the following formula: the lumbar and less abdominal areas develop red spots and pimples of different sizes, partially merge into flakes with scratch and scab. Severe subjective itching, bitter taste, abdominal distension, tooth trace on the tongue, yellow and greasy coating, slippery and rapid pulse, western medicine diagnosis: eczema, diagnosis of traditional Chinese medicine: the medicine composition of the invention is used for treating the wet sore, 14 doses are taken 1 dose per day, the affected part is washed once in the morning and evening, and the re-diagnosis is carried out: the patient had little new rash, had no itching feeling, and was re-diagnosed after 14 doses, without new rash, and the rash was substantially resolved.
The heald is prepared from the following raw materials in parts by weight: 30g of kuh-seng, 12g of amur corktree bark, 12g of red paeony root, 30g of glabrous greenbrier rhizome, 30g of Chinese pulsatilla root, 0.7g of borneol, 15g of belvedere fruit, 15g of dittany bark and 15g of dried alum.
Compared with the prior art, the technical scheme of the application has the following beneficial effects:
the external liquid medicine for treating eczema, the preparation method and the application thereof expand the application range of the medicine for treating eczema, and various traditional Chinese medicines are matched for use, so that the synergistic effect can be exerted, the medicine effect is enhanced, the dampness and heat are removed, the toxin is removed, the dampness is removed, the wind is dispelling and the itching is relieved, the eczema is effectively prevented and treated, the preparation method is simple and easy to implement, the cost is low, the dosage is small, the use is convenient, the heat and moisture are preserved, the medicine is suitable for popularization and application, the skin is kept moist, the skin barrier is repaired, the skin inflammation is resolved, and the curative effect is remarkable.
Claims (9)
1. An external liquid medicine for treating eczema is characterized in that the external liquid medicine comprises the following components: 20-30g of kuh-seng, 6-12g of amur corktree bark, 6-12g of red paeony root, 20-30g of glabrous greenbrier rhizome, 20-30g of Chinese pulsatilla root, 0.5-0.7g of borneol, 10-15g of belvedere fruit, 10-15g of cortex dictamni and 10-15g of dried alum.
2. The external liquid medicine for treating eczema according to claim 1, wherein the external liquid medicine for treating eczema further comprises the following components in parts by weight: 20g of kuh-seng, 6g of amur corktree bark, 6g of red paeony root, 20g of glabrous greenbrier rhizome, 20g of Chinese pulsatilla root, 0.5g of borneol, 10g of belvedere fruit, 10g of dittany bark and 10g of dried alum.
3. The external liquid medicine for treating eczema according to claim 1, wherein the external liquid medicine for treating eczema further comprises the following components in parts by weight: 25g of kuh-seng, 10g of amur corktree bark, 10g of red paeony root, 25g of glabrous greenbrier rhizome, 25g of Chinese pulsatilla root, 0.6g of borneol, 12g of belvedere fruit, 12g of dittany bark and 12g of dried alum.
4. The external liquid medicine for treating eczema according to claim 1, wherein the external liquid medicine for treating eczema further comprises the following components in parts by weight: 30g of kuh-seng, 12g of amur corktree bark, 12g of red paeony root, 30g of glabrous greenbrier rhizome, 30g of Chinese pulsatilla root, 0.7g of borneol, 15g of belvedere fruit, 15g of dittany bark and 15g of dried alum.
5. The method for preparing a liquid medicine for external use for treating eczema according to any one of claims 1 to 4, comprising the steps of:
a. cleaning radix Sophorae Flavescentis, cortex Phellodendri, radix Paeoniae Rubra, rhizoma Smilacis Glabrae, radix Pulsatillae, kochiae fructus, and cortex Dictamni Radicis, respectively, cutting into small pieces, and soaking in water in a decoction pot;
b. decocting the soaked medicinal materials;
c. adding Borneolum Syntheticum and Alumen at a certain proportion 5 min before decocting;
d. filtering the decoction to obtain concentrated Chinese medicinal liquid;
e. adding purified water to dilute the concentrated Chinese medicinal liquid according to the disease condition to obtain the final Chinese medicinal liquid.
6. The method according to claim 5, wherein the soaking time in the step a is 2-3 hours, and the decocting time in the step b is 2-3 hours.
7. The method for preparing a topical medicinal liquid for treating eczema according to claim 5, wherein after the step d is finished, the decoction is filtered by a gauze bag, and the mesh number of the gauze bag is 300 meshes.
8. The method for preparing an external liquid medicine for treating eczema according to claim 5, wherein the dilution method in the step e is to dilute the concentrated liquid medicine with purified water according to the ratio of 1:3, 1:5 and 1:10.
9. An external liquid medicine for treating eczema according to any one of claims 1-8 and a preparation method thereof and application thereof in treating eczema.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311824140.6A CN117530916A (en) | 2023-12-28 | 2023-12-28 | External liquid medicine for treating eczema and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311824140.6A CN117530916A (en) | 2023-12-28 | 2023-12-28 | External liquid medicine for treating eczema and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117530916A true CN117530916A (en) | 2024-02-09 |
Family
ID=89782585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311824140.6A Pending CN117530916A (en) | 2023-12-28 | 2023-12-28 | External liquid medicine for treating eczema and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117530916A (en) |
-
2023
- 2023-12-28 CN CN202311824140.6A patent/CN117530916A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
| CN103721131A (en) | Traditional Chinese medicinal suppository for treating female chronic pelvic inflammation and preparation method thereof | |
| CN101884776B (en) | Chinese preparation for treating hand-foot-and-mouth diseases | |
| CN103007124B (en) | Chinese medicine preparation for treating gynecologic inflammation | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN102018807A (en) | Medicine composition for treating gynaecologic trichomonas vaginitis and preparation method thereof | |
| CN112807399A (en) | A Chinese medicinal tincture for treating dermatoses, and its preparation method | |
| CN115770279B (en) | Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof | |
| CN107737288B (en) | Traditional Chinese medicine composition for treating allergic asthma and preparation method thereof | |
| CN105362839A (en) | Traditional Chinese medicine composition for treating gynecologic inflammation | |
| CN115337379A (en) | External-use medicine composition for treating mammary gland diseases and preparation method thereof | |
| CN1318052C (en) | Medicine compositions for treating acne, and its prepn. method | |
| CN111821346B (en) | Topical anti-inflammatory composition | |
| CN117530916A (en) | External liquid medicine for treating eczema and preparation method thereof | |
| CN112618653A (en) | Chinese medicinal biological preparation for inhibiting HPV and hysteromyoma and its preparation method | |
| CN111743982A (en) | Vulva lotion and preparation method thereof | |
| CN101224281A (en) | Chinese traditional medicine preparation for relieving heat and toxins | |
| CN103479915B (en) | Traditional Chinese medicine composition for treating acute nephritis and preparation method thereof | |
| CN112972559B (en) | Traditional Chinese medicine composition and traditional Chinese medicine mixture for treating bone and soft tissue suppurative inflammation | |
| CN110882270B (en) | Pharmaceutical composition containing silicon-based regenerative medical material and preparation method thereof | |
| CN113018396A (en) | Traditional Chinese medicine composition for treating recurrent urinary tract infection and preparation method thereof | |
| CN107854572B (en) | External traditional Chinese medicine for treating damp-heat stasis type chronic pelvic inflammatory disease pain and preparation method thereof | |
| CN112933154A (en) | Traditional Chinese medicine composition for treating urogenital infection diseases | |
| CN105381410A (en) | Traditional Chinese medicinal preparation for treating hepatitis | |
| CN105031516A (en) | Chinese herbal unguent for curing erysipelas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |